Open Access
Short Note
Volume 20, 2013
Article Number 39
Number of page(s) 5
Published online 22 October 2013
  1. Albright JW, Albright JF. 1980. In vitro growth of Trypanosoma musculi in cell-free medium conditioned by rodent macrophages and mercaptoethanol. International Journal of Parasitology, 10, 137–142. [CrossRef] [Google Scholar]
  2. Bahia MT, de Andrade IM, Martins TA, do Nascimento ÁF, Diniz Lde F, Caldas IS, Talvani A, Trunz BB, Torreele E, Ribeiro I. 2012. Fexinidazole: a potential new drug candidate for Chagas disease. PLoS Neglected Tropical Diseases, 6, e1870. Doi: 10.1371/journal.pntd.0001870 [CrossRef] [PubMed] [Google Scholar]
  3. Balber AE, Sturtevant JE. 1986. A surface glycoprotein of Trypanosoma lewisi binds immunoglobulin G from the serum of uninfected rats. Infection and Immunity, 53, 420–426. [PubMed] [Google Scholar]
  4. Berger BJ, Fairlamb AH. 1992. Interactions between immunity and chemotherapy in the treatment of the trypanosomiases and leishmaniases. Parasitology, 105, S71–S78. [CrossRef] [PubMed] [Google Scholar]
  5. Budovsky A, Prinsloo I, El-On J. 2006. Pathological developments mediated by cyclophosphamide in rats infected with Trypanosoma lewisi. Parasitology International, 55, 237–242. [CrossRef] [PubMed] [Google Scholar]
  6. D’Alessandro PA, Behr MA. 1991. Trypanosoma lewisi and its relatives. In Krerer J, Baker JR (Eds.), Parasitic protozoa. Academic Press, New York, pp. 225–263. [Google Scholar]
  7. Hirumi H, Hirumi K. 1989. Continuous cultivation of Trypanosoma brucei blood stream forms in a medium containing a low concentration of serum protein without feeder cell layers. Journal of Parasitology, 75, 985–989. [CrossRef] [Google Scholar]
  8. Hoare CA. 1972. The Trypanosomes of Mammals. A Zoological Monograph. Blackwell Scientific Publications: Oxford and Edinburgh. p. 1–749. [Google Scholar]
  9. Holzmuller P, Dg Biron, Courtois P, Koffi M, Bras-Gonçalves R, Daulouède S, Solano P, Cuny G, Vincendeau P, Jamonneau V. 2008. Virulence and pathogenicity patterns of Trypanosoma brucei gambiense field isolates in experimentally infected mouse: differences in host immune response modulation by secretome and proteomics. Microbes and Infections, 10, 79–86. [CrossRef] [Google Scholar]
  10. Hosseini pour MC, Napravnik S, Joaki G, Gama S, Mbeye N, Banda B, Martinson F, Hoffman I, Cohen MS. 2007. HIV and parasitic infection and the effect of treatment among adult outpatients in Malawi. Journal of Infectious Diseases, 195, 1278–1282. [CrossRef] [Google Scholar]
  11. Howie S, Guy M, Fleming L, Bailey W, Noyes H. 2006. A Gambian infant with fever and an unexpected blood film. PLoS Medicine, 3, 1508–1512. [CrossRef] [Google Scholar]
  12. Humphrey PA, Ashraf M, Lee CM. 1997. Growth of trypanosomes in vivo, host body weight gains, and food consumption in zinc-deficient mice. Journal of the National Medical Association, 89, 48–56. [PubMed] [Google Scholar]
  13. Johnson PD. 1933. A case of infection by Trypanosoma lewisi in a child. Transaction of the Royal Society Tropical Medicine and Hygiene, 26, 467–468. [CrossRef] [Google Scholar]
  14. Kaiser M, Bray MA, Cal M, Bourdin Trunz B, Torreele E, Brun R. 2011. Antitrypanosomal activity of fexinidazole, a new oral nitroimidazole drug candidate for treatment of sleeping sickness. Antimicrobial Agents Chemotherapy, 55, 5602–5608. [CrossRef] [Google Scholar]
  15. Molyneux D. 1976. Biology of the trypanosomes of the subgenus Herpetosoma, in Biology of the Kinetoplastida. Lumsden WHR, Evans DA (Eds.), Academic Press: London. pp. 285–325. [Google Scholar]
  16. Pomel S, Biot C, Bories C, Loiseau PM. 2013. Antiprotozoal activity of ferroquine. Parasitology Research, 112, 665–669. [CrossRef] [PubMed] [Google Scholar]
  17. Priotto G, Kasparian S, Mutombo W, Ngouama D, Ghorashian S, Arnold U, Ghabri S, Baudin E, Buard V, Kazadi-Kyanza S, Ilunga M, Mutangala W, Pohlig G, Schmid C, Karunakara U, Torreele E, Kande V. 2009. Nifurtimox-eflornithine combination therapy for second-stage African Trypanosoma brucei gambiense trypanosomiasis: a multicentre, randomised, phase III, non-inferiority trial. Lancet, 374, 56–64. [CrossRef] [PubMed] [Google Scholar]
  18. Shrivastava KK, Shrivastava GP. 1974. Two cases of Trypanosoma (Herpetosoma) species infection of man in India. Transaction of the Royal Society Tropical Medicine and Hygiene, 68, 143–144. [CrossRef] [Google Scholar]
  19. Torreele E, Bourdin Trunz B, Tweats D, Kaiser M, Brun R, Fexinidazole. 2010. A new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness. PLoS Neglected Tropical Diseases, 4(12), e923. Doi: 10.1371/journal.pntd.0000923 [CrossRef] [PubMed] [Google Scholar]
  20. Truc P, Büscher P, Cuny G, Mi Gonzatti, Jannin J, Prashant J, Prayag J, Zhao-Rong L, Mattioli R, Pays E, Simarro PP, Geraldes-Teixeira MM, Touratier L, Vincendeau P, Desquesnes M. 2013. Atypical human infections by animal trypanosomes. PLoS Neglected Tropical Diseases, 7(9), e2256, Doi: 10.1371/journal.pntd.0002256 [CrossRef] [PubMed] [Google Scholar]
  21. Vanhamme L, Paturiaux-Hanocq F, Poelvoorde P, Nolan DP, Lins L, Van Den Abbeele J, Pays A, Tebabi P, Van-Xong H, Jacquet A, Moguilevsky N, Dieu M, Kane J, De Baetselier P, Brasseur R, Pays E. 2003. Apolipoprotein L-I is the trypanosome lytic factor of human serum. Nature, 422, 83–87. [CrossRef] [PubMed] [Google Scholar]
  22. Van Voorhis WC. 1990. Therapy and prophylaxis of systemic protozoan infections. Drugs, 40, 176–202. [CrossRef] [PubMed] [Google Scholar]
  23. Verma A, Manchanda S, Kumar N, Sharma A, Goel M. 2011. Trypanosoma lewisi or T. lewisi-like infection in a 37 day old infant. American Journal of Tropical Medicinal and Hygiene, 85, 221–224. [CrossRef] [Google Scholar]
  24. Vincendeau P, Daulouède S, Veyret B, Darde ML, Bouteille B, Lemesre JL. 1992. Nitric oxide-mediated cytostatic activity on Trypanosoma brucei gambiense and Trypanosoma brucei brucei. Experimental Parasitology, 75, 353–360. [CrossRef] [PubMed] [Google Scholar]
  25. Vincendeau P, Caristan A, Pautrizel R. 1981. Macrophage functions during Trypanosoma musculi infection in mice. Infections and Immunity, 34, 78–81. [Google Scholar]
  26. Vincendeau P, Daeron M. 1989. Trypanosoma musculi co-express several receptors binding rodent IgM, IgE, and IgG subclasses. Journal of Immunology, 142, 1702. [Google Scholar]
  27. Vincendeau P, Guillemain B, Daulouede S, Ripert C. 1986. In vitro growth of Trypanosoma musculi requirements of cells and serum-free culture medium. International Journal of Parasitology, 16, 387–390. [CrossRef] [Google Scholar]
  28. Vincendeau P, Daeron M, Daulouede S. 1986. Identification of antibody classes and Fc receptors responsible for phagocytosis of Trypanosoma musculi by mouse macrophages. Infection and Immunity, 53, 600–606. [PubMed] [Google Scholar]
  29. Walzer PD, Kim CK, Foy J, Linke MJ, Cushion MT. 1988. Cationic antitrypanosomal and other antimicrobial agents in the therapy of experimental Pneumocystis carinii pneumonia. Antimicrobial Agents and Chemotherapy, 32, 896–905. [CrossRef] [PubMed] [Google Scholar]
  30. Wyllie S, Patterson S, Stojanovski L, Simeons FR, Norval S, Kime R, Read KD, Fairlamb AH. 2012. The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis. Science Translational Medicine, 4, 119. Doi: 10.1126/scitranslmed.3003326 [CrossRef] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.